These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36497419)

  • 1. Tumour Colonisation of
    Löwenmark T; Löfgren-Burström A; Zingmark C; Ljuslinder I; Dahlberg M; Edin S; Palmqvist R
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parvimonas micra is associated with tumour immune profiles in molecular subtypes of colorectal cancer.
    Löwenmark T; Li X; Löfgren-Burström A; Zingmark C; Ling A; Kellgren TG; Larsson P; Ljuslinder I; Wai SN; Edin S; Palmqvist R
    Cancer Immunol Immunother; 2022 Oct; 71(10):2565-2575. PubMed ID: 35301576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parvimonas micra as a putative non-invasive faecal biomarker for colorectal cancer.
    Löwenmark T; Löfgren-Burström A; Zingmark C; Eklöf V; Dahlberg M; Wai SN; Larsson P; Ljuslinder I; Edin S; Palmqvist R
    Sci Rep; 2020 Sep; 10(1):15250. PubMed ID: 32943695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parvimonas micra, Peptostreptococcus stomatis, Fusobacterium nucleatum and Akkermansia muciniphila as a four-bacteria biomarker panel of colorectal cancer.
    Osman MA; Neoh HM; Ab Mutalib NS; Chin SF; Mazlan L; Raja Ali RA; Zakaria AD; Ngiu CS; Ang MY; Jamal R
    Sci Rep; 2021 Feb; 11(1):2925. PubMed ID: 33536501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of
    Périchon B; Lichtl-Häfele J; Bergsten E; Delage V; Trieu-Cuot P; Sansonetti P; Sobhani I; Dramsi S
    Front Cell Infect Microbiol; 2022; 12():794391. PubMed ID: 35360109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer and gut microbiota studies in China.
    Wang Z; Dan W; Zhang N; Fang J; Yang Y
    Gut Microbes; 2023; 15(1):2236364. PubMed ID: 37482657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiota Profile and Impact of
    de Carvalho AC; de Mattos Pereira L; Datorre JG; Dos Santos W; Berardinelli GN; Matsushita MM; Oliveira MA; Durães RO; Guimarães DP; Reis RM
    Front Oncol; 2019; 9():813. PubMed ID: 31555583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteomyelitis of the Distal Phalanx of the Thumb due to
    Tanaka K; Iwasaki T; Kawano M; Kubota Y; Itonaga I; Tsumura H
    Open Forum Infect Dis; 2020 Aug; 7(8):ofaa330. PubMed ID: 32851111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic biofilm formation by Parvimonas micra and Fusobacterium nucleatum.
    Horiuchi A; Kokubu E; Warita T; Ishihara K
    Anaerobe; 2020 Apr; 62():102100. PubMed ID: 31521732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding the Colorectal Cancer Biomarkers Based on the Human Gut Phageome.
    Shen S; Huo D; Ma C; Jiang S; Zhang J
    Microbiol Spectr; 2021 Dec; 9(3):e0009021. PubMed ID: 34935421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusobacterium nucleatum load in MSI colorectal cancer subtypes.
    Ono T; Yamaguchi T; Takao M; Kojika E; Iijima T; Horiguchi SI
    Int J Clin Oncol; 2022 Oct; 27(10):1580-1588. PubMed ID: 35859218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of the abundance of
    Xu J; Yang M; Wang D; Zhang S; Yan S; Zhu Y; Chen W
    Oncol Lett; 2020 Oct; 20(4):106. PubMed ID: 32831925
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of
    Kim YJ; Kim BK; Park SJ; Kim JH
    World J Gastroenterol; 2021 Aug; 27(29):4879-4889. PubMed ID: 34447232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A newly developed PCR-based method revealed distinct Fusobacterium nucleatum subspecies infection patterns in colorectal cancer.
    Bi D; Zhu Y; Gao Y; Li H; Zhu X; Wei R; Xie R; Wei Q; Qin H
    Microb Biotechnol; 2021 Sep; 14(5):2176-2186. PubMed ID: 34309194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral presence of the genotoxic gut bacteria pks
    Joo JE; Chu YL; Georgeson P; Walker R; Mahmood K; Clendenning M; Meyers AL; Como J; Joseland S; Preston SG; Diepenhorst N; Toner J; Ingle DJ; Sherry NL; Metz A; Lynch BM; Milne RL; Southey MC; Hopper JL; Win AK; Macrae FA; Winship IM; Rosty C; Jenkins MA; Buchanan DD
    Br J Cancer; 2024 Mar; 130(5):728-740. PubMed ID: 38200234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parvimonas micra infection enhances proliferation, wound healing, and inflammation of a colorectal cancer cell line.
    Hatta MNA; Mohamad Hanif EA; Chin SF; Low TY; Neoh HM
    Biosci Rep; 2023 Jun; 43(6):. PubMed ID: 37218575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parvimonas micra promotes colorectal tumorigenesis and is associated with prognosis of colorectal cancer patients.
    Zhao L; Zhang X; Zhou Y; Fu K; Lau HC; Chun TW; Cheung AH; Coker OO; Wei H; Wu WK; Wong SH; Sung JJ; To KF; Yu J
    Oncogene; 2022 Sep; 41(36):4200-4210. PubMed ID: 35882981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis.
    Mima K; Nishihara R; Qian ZR; Cao Y; Sukawa Y; Nowak JA; Yang J; Dou R; Masugi Y; Song M; Kostic AD; Giannakis M; Bullman S; Milner DA; Baba H; Giovannucci EL; Garraway LA; Freeman GJ; Dranoff G; Garrett WS; Huttenhower C; Meyerson M; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S
    Gut; 2016 Dec; 65(12):1973-1980. PubMed ID: 26311717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between
    Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
    World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal
    Shen X; Li J; Li J; Zhang Y; Li X; Cui Y; Gao Q; Chen X; Chen Y; Fang JY
    Front Oncol; 2021; 11():661048. PubMed ID: 34046355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.